SELAS GRANDE PHARMACIE DE LA CROIX ROUGE : revenue, balance sheet and financial ratios

SELAS GRANDE PHARMACIE DE LA CROIX ROUGE is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ANTIBES (06600), this company of category PME shows in 2021 a revenue of 3.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS GRANDE PHARMACIE DE LA CROIX ROUGE (SIREN 533369666)
Indicator 2023 2021 2020 2019 2017 2016
Revenue N/C 3 903 571 € 3 716 951 € 3 763 769 € 3 780 999 € 3 798 474 €
Net income 104 663 € 124 345 € 101 486 € 101 481 € 231 938 € 263 456 €
EBITDA N/C 202 707 € 159 523 € 230 106 € 338 150 € 349 633 €
Net margin N/C 3.2% 2.7% 2.7% 6.1% 6.9%

Revenue and income statement

In 2023, SELAS GRANDE PHARMACIE DE LA CROIX ROUGE generates positive net income of 105 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 263 k€ -> 105 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

104 663 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

79.812%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

46.881%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

39.0%

Solvency indicators evolution
SELAS GRANDE PHARMACIE DE LA CROIX ROUGE

Sector positioning

Debt ratio
79.81 2023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average

In 2023, the debt ratio of SELAS GRANDE PHARMACIE DE... (79.81) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
46.88% 2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average

In 2023, the financial autonomy of SELAS GRANDE PHARMACIE DE... (46.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
14.19 years 2021
2020
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Average

In 2021, the repayment capacity of SELAS GRANDE PHARMACIE DE... (14.19) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 93.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

93.725

Liquidity indicators evolution
SELAS GRANDE PHARMACIE DE LA CROIX ROUGE

Sector positioning

Liquidity ratio
93.72 2023
2020
2021
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch -19 pts over 3 years

In 2023, the liquidity ratio of SELAS GRANDE PHARMACIE DE... (93.72) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
14.19x 2021
2020
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Excellent

In 2021, the interest coverage of SELAS GRANDE PHARMACIE DE... (14.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS GRANDE PHARMACIE DE LA CROIX ROUGE

Positioning of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE is estimated at 1 234 968 € (range 751 043€ - 1 736 088€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
751k€ 1234k€ 1736k€
1 234 968 € Range: 751 043€ - 1 736 088€
NAF 5 année 2023

Valuation method used

Net Income Multiple
104 663 € × 11.8x = 1 234 969 €
Range: 751 043€ - 1 736 089€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS GRANDE PHARMACIE DE LA CROIX ROUGE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS GRANDE PHARMACIE DE LA CROIX ROUGE

What is the revenue of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE ?

The revenue of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE in 2021 is 3.9 M€.

Is SELAS GRANDE PHARMACIE DE LA CROIX ROUGE profitable?

Yes, SELAS GRANDE PHARMACIE DE LA CROIX ROUGE generated a net profit of 105 k€ in 2023.

Where is the headquarters of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE ?

The headquarters of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE is located in ANTIBES (06600), in the department Alpes-Maritimes.

Where to find the tax return of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE ?

The tax return of SELAS GRANDE PHARMACIE DE LA CROIX ROUGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS GRANDE PHARMACIE DE LA CROIX ROUGE operate?

SELAS GRANDE PHARMACIE DE LA CROIX ROUGE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.